Latest SRNE reports update at 2023-05-15: 2023-Q1 ∙ 2022-Q4 ∙ 2022-Q1
  1. Home
  2. Stock quotes
  3. Sorrento Therapeutics
  4. Financial Ratios
  5. EV/EBITDA Ratio
Sorrento Therapeutics logo
Sorrento Therapeutics SRNE
$ 0.27 -29.58%
mail-toReport an Error

Sorrento Therapeutics EV/EBITDA Ratio 2011-2024 | SRNE

Annual EV/EBITDA Ratio Sorrento Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-3.01 -15 -3.81 -2.41 9.33 -3.88 -3.36 -6.51 -8.38 -14.5 -16.6

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
9.33 -16.6 -6.2